Analysis of Vaccination Rates of 23-Valent Pneumococcal Polysaccharide Vaccine in Hospitalized Patients with Diabetes

被引：0
|
作者：
Seagroves, Amy
Reh, Christina S.
Bischoff, Nathaniel
Nally, Laura M.
Singh, Jasjit
机构：
来源：
DIABETES | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1409-P
引用
收藏
页码：A377 / A378
页数：2
相关论文
共 50 条
  • [21] COST-EFFECTIVENESS OF 13-VALENT VERSUS 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE AND NO VACCINATION IN THE CZECH NATIONAL VACCINATION PROGRAM
    Zigmond, J.
    Tichopad, A.
    Kolek, V
    Roberts, C. S.
    Hajek, P.
    VALUE IN HEALTH, 2013, 16 (03) : A73 - A74
  • [22] Priming of immunological memory by pneumococcal conjugate vaccine in children unresponsive to 23-valent polysaccharide pneumococcal vaccine
    Rose, MA
    Schubert, R
    Strnad, N
    Zielen, S
    CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2005, 12 (10) : 1216 - 1222
  • [23] SERUM ANTIBODY-RESPONSES TO VACCINATION WITH 23-VALENT PNEUMOCOCCAL VACCINE IN SPLENECTOMIZED PATIENTS
    REINERT, RR
    KAUFHOLD, A
    KUHNEMUND, O
    LUTTICKEN, R
    ZENTRALBLATT FUR BAKTERIOLOGIE-INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY VIROLOGY PARASITOLOGY AND INFECTIOUS DISEASES, 1994, 281 (04): : 481 - 490
  • [24] The Serological Response Of Asthmatics To The 23-Valent Pneumococcal Polysaccharide Vaccine (ppsv23)
    Laratta, C. R.
    Williams, K.
    Vethanayagam, D.
    Ulanova, M.
    Vliagoftis, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [25] Decreased immune response to pneumococcal conjugate vaccine after 23-valent pneumococcal polysaccharide vaccine in children
    Sigurdardottir, Sigurveig Th.
    Center, Kimberly J.
    Davidsdottir, Katrin
    Arason, Vilhjalmur A.
    Hjalmarsson, Bjorn
    Elisdottir, Ragnheidur
    Ingolfsdottir, Gunnhildur
    Northington, Robert
    Scott, Daniel A.
    Jonsdottir, Ingileif
    VACCINE, 2014, 32 (03) : 417 - 424
  • [26] PHARMACOECONOMIC EVALUATION OF 13-VALENT PNEUMOCOCCAL CONJUGATE AND 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE IN CANADIAN ADULTS
    Chuck, A.
    Waye, A.
    Zanotti, G.
    Jacobs, P.
    Kellner, J.
    Tyrrell, G.
    VALUE IN HEALTH, 2012, 15 (04) : A243 - A243
  • [27] Cardiovascular, Neurological, and Immunological Adverse Events and the 23-Valent Pneumococcal Polysaccharide Vaccine
    Yoon, Dongwon
    Jeon, Ha-Lim
    Kim, Ju Hwan
    Lee, Hyesung
    Shin, Ju-Young
    JAMA NETWORK OPEN, 2024, 7 (01) : E2352597
  • [28] Evaluation of effectiveness of the 23-valent pneumococcal capsular polysaccharide vaccine for HIV-infected patients
    Breiman, RF
    Keller, DW
    Phelan, MA
    Sniadack, DH
    Stephens, DS
    Rimland, D
    Farley, MM
    Schuchat, A
    Reingold, AL
    ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (17) : 2633 - 2638
  • [29] TOLERABILITY AND SAFETY OF 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE IN PATIENTS WITH SYSTEMIC VASCULITIS, PRELIMINARY RESULTS
    Tarasova, G.
    Egorova, O.
    Reshetnyak, T.
    Belov, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1435 - 1435
  • [30] TOLERABILITY AND SAFETY OF 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME, PRELIMINARY RESULTS
    Tarasova, G.
    Belov, B.
    Cherkasova, M.
    Aseeva, E.
    Reshetnyak, T.
    Kosheleva, N.
    Popkova, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1180 - 1181
12345